N. Hynes

发表

The biology of erbB-2/neu/HER-2 and its role in cancer.

N. Hynes, D. Stern, N. Hynes, 1994, Biochimica et biophysica acta.

The int-2 gene product acts as a growth factor and substitutes for basic fibroblast growth factor in promoting the differentiation of a normal mouse mammary epithelial cell line.

G. Merlo, D. Taverna, D. Salomon, 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density.

E. Kornilova, D. Taverna, N. Hynes, 1992, Oncogene.

NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells.

D. Taverna, B. Marte, N. Hynes, 1995, Oncogene.

New acceptor cell for transfected genomic DNA: oncogene transfer into a mouse mammary epithelial cell line

B. Groner, R. Jaggi, S. Kozma, 1985 .

Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences.

B. Groner, S. Kozma, N. Hynes, 1988, The EMBO journal.

Oncogenic activation of the human trk proto‐oncogene by recombination with the ribosomal large subunit protein L7a.

S. Kozma, A. Ziemiecki, N. Hynes, 1990, The EMBO journal.

Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells

D. Taverna, B. Groner, D. Salomon, 1990, Molecular and cellular biology.

Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene.

F. Ciardiello, R. Callahan, D. Liscia, 1988, Molecular endocrinology.

Mammary gland development and lactation are controlled by different glucocorticoid receptor activities.

H. Beug, A. Kolbus, G. Schütz, 2001, European journal of endocrinology.

The epithelium‐specific Ets transcription factor ESX is associated with mammary gland development and involution

R. Neve, C. Benz, G. Scott, 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates

R. Langlois, M. Dorvillius, C. Larroque, 2001, British Journal of Cancer.

p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin

F. Basolo, N. Hynes, L. Fiore, 1995, The Journal of cell biology.

Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.

Masui, Ciardiello, F. Ciardiello, 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Oestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms.

D. Taverna, N. Hynes, N. Hynes, 1994, British Journal of Cancer.

Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors.

D. Taverna, B. Marte, N. Hynes, 1996, European journal of cell biology.

Growth suppression of normal mammary epithelial cells by wild-type p53.

D. Taverna, T. Venesio, R. Callahan, 1994, Oncogene.

Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth.

N. Hynes, W. Wels, M. Müller, 1993, British Journal of Cancer.